{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:21Z","timestamp":1792181721897,"version":"4.4.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200800056C"],"award-info":[{"award-number":["HHSN272200800056C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0192312","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T13:37:03Z","timestamp":1519133823000},"page":"e0192312","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates"],"prefix":"10.1371","volume":"13","author":[{"given":"Benoit","family":"Callendret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jort","family":"Vellinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Steigerwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Dirmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Cheminay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Brasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis D.","family":"Giavedoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Mire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Weijtens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Hartkoorn-Pasma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Custers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grazia Pau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2822-6231","authenticated-orcid":true,"given":"Roland","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"9","key":"ref1","first-page":"442","article-title":"Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis","volume":"72","author":"M Goeijenbier","year":"2014","journal-title":"Neth J Med"},{"key":"ref2","unstructured":"World Health Organization. Ebola virus disease. Fact sheet [updated June 2017]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e04395","DOI":"10.7554\/eLife.04395","article-title":"Mapping the zoonotic niche of Ebola virus disease in Africa","volume":"3","author":"DM Pigott","year":"2014","journal-title":"eLife"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/trstmh\/trv024","article-title":"Mapping the zoonotic niche of Marburg virus disease in Africa","volume":"109","author":"DM Pigott","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref5","unstructured":"International Committee on Taxonomy of Viruses. Virus Taxonomy: 2016 Release. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/talk.ictvonline.org\/taxonomy\/\" xlink:type=\"simple\">https:\/\/talk.ictvonline.org\/taxonomy\/<\/ext-link>"},{"issue":"5","key":"ref6","first-page":"1229","article-title":"Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA","volume":"159","author":"JH Kuhn","year":"2014","journal-title":"Arch Virol"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"e1002304","DOI":"10.1371\/journal.ppat.1002304","article-title":"Discovery of an ebolavirus-like filovirus in europe","volume":"7","author":"A Negredo","year":"2011","journal-title":"PLoS Pathog"},{"issue":"9996","key":"ref8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"AM Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"10068","key":"ref9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"AM Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12916-015-0477-2","article-title":"Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control","volume":"13","author":"CE Coltart","year":"2015","journal-title":"BMC Med"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/1744666X.2014.908705","article-title":"Characterization of host immune responses in Ebola virus infections","volume":"10","author":"G Wong","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14760584.2014.885841","article-title":"Ebola virus vaccines: an overview of current approaches","volume":"13","author":"A Marzi","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"14","key":"ref13","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus","volume":"83","author":"TW Geisbert","year":"2009","journal-title":"J Virol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"LE Hensley","year":"2010","journal-title":"PLoS Pathog"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"e2600","DOI":"10.1371\/journal.pntd.0002600","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus","volume":"7","author":"CE Mire","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"SM Jones","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00431-07","article-title":"Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections","volume":"15","author":"DL Swenson","year":"2008","journal-title":"Clin Vaccine Immuno"},{"issue":"19","key":"ref18","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","volume":"80","author":"KM Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"A Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"TC Mast","year":"2010","journal-title":"Vaccine"},{"issue":"32","key":"ref21","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"DH Barouch","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"e44115","DOI":"10.1371\/journal.pone.0044115","article-title":"Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species","volume":"7","author":"R Zahn","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/hum.2013.235","article-title":"Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field","volume":"25","author":"D Majhen","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"15","key":"ref24","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial","volume":"315","author":"ID Milligan","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"DF Hoft","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"TW Geisbert","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"e0131571","DOI":"10.1371\/journal.pone.0131571","article-title":"Ad35.CS.01 - RTS,S\/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naive Adults","volume":"10","author":"CF Ockenhouse","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/infdis\/jis671","article-title":"Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)","volume":"207","author":"DH Barouch","year":"2013","journal-title":"J Infect Dis"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"DA Stanley","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial","volume":"16","author":"MD Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.2016.20644","article-title":"Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored Ebola vaccines at 1 Year","volume":"317","author":"RL Winslow","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"NJ Sullivan","year":"2006","journal-title":"PLoS Med"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"S Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"issue":"17","key":"ref34","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1128\/JVI.00604-10","article-title":"Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses","volume":"84","author":"K Baur","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/JVI.54.1.30-37.1985","article-title":"In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals","volume":"54","author":"MA Cochran","year":"1985","journal-title":"J Virol"},{"key":"ref36","first-page":"77","article-title":"Construction and isolation of recombinant MVA","volume":"269","author":"C Staib","year":"2004","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2043-9113-2-5","article-title":"Monte Carlo simulation of the Spearman-Kaerber TCID50","volume":"2","author":"NH Wulff","year":"2012","journal-title":"J Clin Bioinforma"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3390\/v6072673","article-title":"Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop","volume":"6","author":"R Hirschberg","year":"2014","journal-title":"Viruses"},{"issue":"13","key":"ref39","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.00069-06","article-title":"Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola","volume":"80","author":"JS Towner","year":"2006","journal-title":"J Virol"},{"issue":"Suppl 2","key":"ref40","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1093\/infdis\/jiv216","article-title":"Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus","volume":"212","author":"KJ Alfson","year":"2015","journal-title":"J Infect Dis"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.3390\/v7122969","article-title":"Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material","volume":"7","author":"JC Trefry","year":"2015","journal-title":"Viruses"},{"issue":"13","key":"ref42","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1128\/JVI.00649-15","article-title":"Particle to plaque-forming unit ratio of Ebola virus influences disease course and survival in cynomolgus macaques","volume":"89","author":"KJ Alfson","year":"2015","journal-title":"J Virol"},{"issue":"Suppl 2","key":"ref43","doi-asserted-by":"crossref","first-page":"S443","DOI":"10.1093\/infdis\/jiv316","article-title":"Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus","volume":"212","author":"D Matassov","year":"2015","journal-title":"J Infect Dis"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1080\/21645515.2015.1039757","article-title":"Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges","volume":"11","author":"RJ Grant-Klein","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1089\/vim.2014.0071","article-title":"Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein","volume":"28","author":"K Martins","year":"2015","journal-title":"Viral Immunol"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.vaccine.2016.11.083","article-title":"Comparison of platform technologies for assaying antibody to Ebola virus","volume":"35","author":"DE Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4161\/hv.21873","article-title":"A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge","volume":"8","author":"RJ Grant-Klein","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl3","key":"ref48","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"TW Geisbert","year":"2011","journal-title":"J Infect Dis"},{"issue":"286","key":"ref49","doi-asserted-by":"crossref","first-page":"286ps11","DOI":"10.1126\/scitranslmed.aaa8202","article-title":"Immunology of protection from Ebola virus infection","volume":"7","author":"PR Krause","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"e0150919","DOI":"10.1371\/journal.pone.0150919","article-title":"Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus\/H.sapiens-tc\/COD\/1995\/Kikwit-9510621 Challenge Stock &quot;R4368&quot; and Its Replacement &quot;R4415&quot;","volume":"11","author":"JR Kugelman","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"NJ Sullivan","year":"2011","journal-title":"Nat Med"},{"issue":"6202","key":"ref52","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"SK Gire","year":"2014","journal-title":"Science"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cell.2015.06.007","article-title":"Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone","volume":"161","author":"DJ Park","year":"2015","journal-title":"Cell"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/erv.10.152","article-title":"Progress in filovirus vaccine development: evaluating the potential for clinical use","volume":"10","author":"D Falzarano","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/v3070982","article-title":"Correlates of immunity to filovirus infection","volume":"3","author":"SB Bradfute","year":"2011","journal-title":"Viruses"},{"issue":"13","key":"ref56","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"JM Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"ref57","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"GG Olinger Jr.","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7520","key":"ref58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"X Qiu","year":"2014","journal-title":"Nature"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"A Marzi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2129","article-title":"Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule","volume":"7","author":"NJ Sullivan","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"158","key":"ref61","doi-asserted-by":"crossref","first-page":"158ra46","DOI":"10.1126\/scitranslmed.3004582","article-title":"Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates","volume":"4","author":"G Wong","year":"2012","journal-title":"Sci Transl Med"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0196546","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0192312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T06:04:06Z","timestamp":1603865046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0192312"}},"subtitle":[],"editor":[{"given":"Jens H.","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0192312","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]}}}